At the end of the latest market close, Onconova Therapeutics Inc. (ONTX) was valued at $0.63. In that particular session, Stock kicked-off at the price of $0.63 while reaching the peak value of $0.665 and lowest value recorded on the day was $0.619. The stock current value is $0.63.
Recently in News on January 7, 2021, Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering. Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain institutional accredited investors to purchase in a registered direct offering 19,550,562 shares of its common stock at a purchase price of $0.445 per share. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Onconova Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.9490 on 01/05/21, with the lowest value was $0.4350 for the same time period, recorded on 01/04/21.
Onconova Therapeutics Inc. (ONTX) full year performance was 38.62%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Onconova Therapeutics Inc. shares are logging -59.29% during the 52-week period from high price, and 234.03% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $1.56.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 24039638 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Onconova Therapeutics Inc. (ONTX) recorded performance in the market was 36.32%, having the revenues showcasing 129.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 117.30M, as it employees total of 25 workers.
Onconova Therapeutics Inc. (ONTX) in the eye of market guru’s
During the last month, 0 analysts gave the Onconova Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3428, with a change in the price was noted -0.3950. In a similar fashion, Onconova Therapeutics Inc. posted a movement of -38.35% for the period of last 100 days, recording 23,091,072 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ONTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Onconova Therapeutics Inc. (ONTX): Stocks Technical analysis and Trends
Raw Stochastic average of Onconova Therapeutics Inc. in the period of last 50 days is set at 55.71%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.47%. In the last 20 days, the company’s Stochastic %K was 52.31% and its Stochastic %D was recorded 58.64%.
If we look into the earlier routines of Onconova Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 36.32%. Additionally, trading for the stock in the period of the last six months notably improved by 11.89%, alongside a boost of 38.62% for the period of the last 12 months. The shares increased approximately by 36.32% in the 7-day charts and went down by 102.42% in the period of the last 30 days. Common stock shares were driven by 129.24% during last recorded quarter.